Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study.
暂无分享,去创建一个
J J Mallet | E Angelie | A Bonmartin | D Sappey-Marinier | D. Sappey-Marinier | E. Angelié | J. Mallet | A. Bonmartin | A. Boudraa | P. Gonnaud | A Boudraa | P M Gonnaud
[1] B. Sykes,et al. Water Eliminated Fourier Transform NMR Spectroscopy , 1972 .
[2] D. Gadian,et al. Magnetic resonance spectroscopy in temporal lobe epilepsy , 1994, Neurology.
[3] D. Louis Collins,et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy , 1996, Nature Medicine.
[4] Peter Boesiger,et al. Quantitative 1H MRS of the human brain in vivo based on the simulation phantom calibration strategy , 1998, Magnetic resonance in medicine.
[5] R. Kikinis,et al. Age-related changes in intracranial compartment volumes in normal adults assessed by magnetic resonance imaging. , 1996, Journal of neurosurgery.
[6] G. Fein,et al. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging , 1994, Annals of neurology.
[7] D. Gadian,et al. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[8] G. Matson,et al. Neuron loss localizes human temporal lobe epilepsy by in vivo proton magnetic resonance spectroscopic imaging , 1993, Annals of neurology.
[9] Julius T. Tou,et al. Pattern Recognition Principles , 1974 .
[10] James Feeney,et al. Data shift accumulation and alternate delay accumulation techniques for overcoming the dynamic range problem , 1980 .
[11] Jullie W Pan,et al. Quantitative spectroscopic imaging of the human brain , 1998, Magnetic resonance in medicine.
[12] D. Head,et al. Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. , 1997, Cerebral cortex.
[13] J. Meyer,et al. Cerebral circulation in the elderly. , 1993, Cerebrovascular and brain metabolism reviews.
[14] Jeff H. Duyn,et al. Transsynaptic Reduction in N‐Acetyl‐Aspartate in Cerebellar Diaschisis: A Proton MR Spectroscopic Imaging Study , 1994, Journal of computer assisted tomography.
[15] G. Šimić,et al. Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease , 1997, The Journal of comparative neurology.
[16] O Almkvist,et al. White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. , 1992, Archives of neurology.
[17] A. Alavi,et al. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] T. Shirao,et al. Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease. , 1999, Journal of neuropathology and experimental neurology.
[19] V. Haughton,et al. Neuropsychological test findings in subjects with leukoaraiosis. , 1989, Archives of neurology.
[20] K O Lim,et al. Decreased gray matter in normal aging: an in vivo magnetic resonance study. , 1992, Journal of gerontology.
[21] J. Vion-Dury,et al. Localized brain proton MRS metabolic patterns in HIV-related encephalopathies. , 1994, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.
[22] J. Frahm,et al. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites , 1989, Magnetic resonance in medicine.
[23] J. Trojanowski,et al. Human fetal hippocampal development: I. Cytoarchitecture, myeloarchitecture, and neuronal morphologic features , 1996, The Journal of comparative neurology.
[24] K. Krishnan,et al. Proton spectroscopy of human brain: Effects of age and sex , 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[25] Shi-Jiang Li,et al. Differentiation of metabolic concentrations between gray matter and white matter of human brain by in vivo 1H magnetic resonance spectroscopy , 1998, Magnetic resonance in medicine.
[26] P. Narayana,et al. Relative Concentrations of Proton MR Visible Neurochemicals in Gray and White Matter in Human Brain , 1995, Magnetic resonance in medicine.
[27] H. Larsson,et al. The concentration of N-acetyl aspartate, creatine + phosphocreatine, and choline in different parts of the brain in adulthood and senium. , 1993, Magnetic resonance imaging.
[28] Roland Kreis,et al. Development of the human brain: In vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy , 1993, Magnetic resonance in medicine.
[29] D. Graham,et al. Aging‐associated Changes in Human Brain , 1997, Journal of neuropathology and experimental neurology.
[30] G. Fein,et al. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease , 1997, Neurology.
[31] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[32] J. Frahm,et al. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS , 1998, Magnetic resonance in medicine.
[33] George Fein,et al. Proton magnetic resonance spectroscopy of human brain: Applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities , 1992, Magnetic resonance in medicine.
[34] K. Double,et al. Topography of brain atrophy during normal aging and alzheimer's disease , 1996, Neurobiology of Aging.
[35] G Tedeschi,et al. Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging , 1995, Neurology.
[36] B. Miller. A review of chemical issues in 1H NMR spectroscopy: N‐acetyl‐l‐aspartate, creatine and choline , 1991, NMR in biomedicine.
[37] Gioacchino Tedeschi,et al. MR image segmentation and tissue metabolite contrast in 1H spectroscopic imaging of normal and aging brain , 1999, Magnetic resonance in medicine.
[38] G. Fein,et al. H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia. , 1995, Radiology.
[39] R. Lesser,et al. Proton MR spectroscopy in patients with seizure disorders. , 1994, AJNR. American journal of neuroradiology.
[40] R. DeTeresa,et al. Neocortical cell counts in normal human adult aging , 1987, Annals of neurology.
[41] Richard S. J. Frackowiak,et al. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. , 1990, Brain : a journal of neurology.
[42] K O Lim,et al. In vivo spectroscopic quantification of the N‐acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: Effects of normal aging , 1999, Magnetic resonance in medicine.
[43] J R Griffiths,et al. Aging of the adult human brain: In vivo quantitation of metabolite content with proton magnetic resonance spectroscopy , 1999, Journal of magnetic resonance imaging : JMRI.
[44] D Comar,et al. Regional Cerebral Blood Flow and Oxygen Consumption in Human Aging , 1984, Stroke.
[45] R. Kikinis,et al. White matter changes with normal aging , 1998, Neurology.
[46] T. Ernst,et al. Abnormal cerebral metabolite concentrations in patients with probable alzheimer disease , 1994, Magnetic resonance in medicine.
[47] J. Neale,et al. Immunohistochemical localization of N-acetylaspartate in rat brain. , 1991, Neuroreport.
[48] H. Blumenthal,et al. Dementia of the Aged: Disease or Atypical‐Accelerated Aging? Biopathological and Psychological Perspectives , 1992, Journal of the American Geriatrics Society.
[49] D J Jenden,et al. In vivo proton magnetic resonance spectroscopy of the normal aging human brain. , 1996, Life sciences.
[50] L Symon,et al. Investigation into the Role of N‐Acetylaspartate in Cerebral Osmoregulation , 1995, Journal of neurochemistry.
[51] C. Segebarth,et al. Quantitative 31P MRS of the normal adult human brain. Assessment of interindividual differences and ageing effects , 1993, NMR in biomedicine.
[52] P M Matthews,et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. , 1998, Brain : a journal of neurology.
[53] Jullie W Pan,et al. Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1T , 1994, Magnetic resonance in medicine.
[54] William H. Oldendorf,et al. N-Acetyl-L-Aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain , 1989, Neuroscience & Biobehavioral Reviews.
[55] Jens Frahm,et al. Localized proton MRS of the human hippocampus: Metabolite concentrations and relaxation times , 1999, Magnetic resonance in medicine.
[56] K. Lim,et al. Estimating NAA in cortical gray matter with applications for measuring changes due to aging , 1997, Magnetic resonance in medicine.
[57] A. Blamire,et al. Early Temporal Variation of Cerebral Metabolites After Human Stroke: A Proton Magnetic Resonance Spectroscopy Study , 1993, Stroke.
[58] J. Duyn,et al. Quantitative proton MR spectroscopic imaging of the human brain , 1996, Magnetic resonance in medicine.
[59] K. Takenouchi,et al. Metabolite changes with age measured by proton magnetic resonance spectroscopy in normal subjects , 1997 .
[60] Daniel H. Mathalon,et al. Age-related decline in MRI volumes of temporal lobe gray matter but not hippocampus , 1995, Neurobiology of Aging.